Silica Nanoparticle Exposure Implicates β-Amyloid (1–42) Inbound and the Accelerating Alzheimer’s Disease Progression in Mice Overexpressing Mutated Forms of Human Amyloid Precursor Protein and Presenilin 1 Genes
Chemical Research in Toxicology · 2024
DOI: 10.1021/acs.chemrestox.3c00378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2024. Verfasst von Wei Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beiji…. Hauptthemen laut MEDLINE: Alzheimer Disease, Nanoparticles, Peptide Fragments. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Science Fund for Distinguished Young Scholars of Chongqing Municipality, National Natural Science Foundation of China, Innovation Research Group at higher Education Institutions in Chongqing, Chongqing Education Committee.
Themen: Demenz
Abstract (Originalsprache)
The increasing nanoparticle (NP) applications in the biomedical field have become an emerging concern regarding human health. NP exposure may play a role in the accelerating Alzheimer's disease (AD) progression; however, the etiology of this disorder is complex and remains largely unclear. Here, we identified that intravenous injection of silica NPs (SiNPs) caused the blood-brain barrier breakdown via downregulating tight junction-related gene expressions. Meanwhile, SiNPs upregulate the transport receptor for advanced glycation end products (RAGE) that govern the β-amyloid (Aβ) influx to the brain; however, low-density lipoprotein receptor-related protein 1 (LRP1) that controls the efflux of Aβ from the brain was not affected. Consequently, an increase in Aβ burden in the brain of SiNP-challenged APP/PS1 mice was found. Intriguingly, plasma apolipoprotein E (ApoE) adsorbed on the surface of SiNPs partially relieves this effect. Using ApoE knockout (ApoE-/-) mice, we confirmed that SiNPs covered with serum without ApoE showed further elevated AD symptoms. Together, this study offered a compilation of data to support the potential risk factors of NP exposure and AD pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.
- Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
ORCID-Profile: Erqun Song, Yang Song
Förderung
- Science Fund for Distinguished Young Scholars of Chongqing Municipality
- National Natural Science Foundation of China
- Innovation Research Group at higher Education Institutions in Chongqing, Chongqing Education Committee
Zitieren
APA
Wei, W., Sun, H., Yang, B., Zhu, C., Song, E., & Song, Y. (2024). Silica Nanoparticle Exposure Implicates β-Amyloid (1–42) Inbound and the Accelerating Alzheimer’s Disease Progression in Mice Overexpressing Mutated Forms of Human Amyloid Precursor Protein and Presenilin 1 Genes. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.3c00378
Vancouver
Wei W, Sun H, Yang B, Zhu C, Song E, Song Y. Silica Nanoparticle Exposure Implicates β-Amyloid (1–42) Inbound and the Accelerating Alzheimer’s Disease Progression in Mice Overexpressing Mutated Forms of Human Amyloid Precursor Protein and Presenilin 1 Genes. Chemical Research in Toxicology. 2024. doi:10.1021/acs.chemrestox.3c00378
BibTeX
@article{Wei2024,
author = {Wei, Wei and Sun, Hang and Yang, Bingwei and Zhu, Chengyu and Song, Erqun and Song, Yang},
title = {Silica Nanoparticle Exposure Implicates β-Amyloid (1–42) Inbound and the Accelerating Alzheimer’s Disease Progression in Mice Overexpressing Mutated Forms of Human Amyloid Precursor Protein and Presenilin 1 Genes},
journal = {Chemical Research in Toxicology},
year = {2024},
doi = {10.1021/acs.chemrestox.3c00378}
}
EUVIMED